Heligenics

Las Vegas, NV · Founded 2015 · Privately Held (backing)

Developer of a medicinal drug designed to prevent disease and heal patients afflicted with illness through genomics. Heligenics is based in Las Vegas, NV and was founded in 2015. Its last reported valuation was $17.2 million in Aug 2022. It has raised $6 million across 3 recorded rounds; the latest was a $2.6 million seed round in Aug 2024.

Last reported valuation
$17.2M
Oct 2026
Priced at
—
Total raised
$6.0M
Last round
Seed Round
Aug 2024
What is Heligenics worth?
$17.2Mlast reported valuation · Oct 2026

Heligenics's last reported valuation, Aug 2022. Nothing priced has surfaced since.

Free account
More of Heligenics with a free account
  • ·Watch Heligenics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Heligenics funding history

3 rounds
DateRoundRaisedPost-money
Aug 2024Seed Round$2.6M▮
Jun 2022Seed Round$2.2M▮
Mar 2020Seed Round$1.2M▮
Unlock post-money valuations

Membership and data by Private Market View

Heligenics valuation

Heligenics's last reported valuation was $17.2 million in Aug 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Heligenics raised?

Heligenics has raised $6 million across 3 recorded rounds since 2020. The largest was a $2.6 million seed round in Aug 2024.

Heligenics has filed 3 Form Ds with the SEC since 2020, most recently in Jan 2025 ($2.6 million sold to 8 investors).

How Heligenics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Heligenics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Heligenics

What is Heligenics worth?
Heligenics is valued at $17.2M as of Oct 2026. Heligenics's last reported valuation, Aug 2022. Nothing priced has surfaced since.
How much has Heligenics raised?
Heligenics has raised $6.0M in total funding across 3 recorded rounds.
When did Heligenics last raise?
Heligenics last raised in Aug 2024 (Seed Round), raising $2.6M.